Boston Scientific Contract with Customer, Liability increased by 0.9% to $668.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.1%, from $618.00M to $668.00M. Over 4 years (FY 2020 to FY 2024), Contract with Customer, Liability shows an upward trend with a 12.6% CAGR.
other_contract_with_customer_liability| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $424.00M | $455.00M | $484.00M | $491.00M | $501.00M | $494.00M | $509.00M | $521.00M | $537.00M | $547.00M | $577.00M | $593.00M | $599.00M | $618.00M | $635.00M | $641.00M | $662.00M | $668.00M |
| QoQ Change | — | +7.3% | +6.4% | +1.4% | +2.0% | -1.4% | +3.0% | +2.4% | +3.1% | +1.9% | +5.5% | +2.8% | +1.0% | +3.2% | +2.8% | +0.9% | +3.3% | +0.9% |
| YoY Change | — | — | — | — | +18.2% | +8.6% | +5.2% | +6.1% | +7.2% | +10.7% | +13.4% | +13.8% | +11.5% | +13.0% | +10.1% | +8.1% | +10.5% | +8.1% |